Before a regenerative hair injectable course

Before starting a regenerative hair injectable course, obtain a dated written plan. It should identify the material and its source, state each proposed session and why that timetable was chosen, set a review and stopping rule, name the accountable clinician and redress route, and explain what happens if there is no change.

What this pre-course record is for

A regenerative hair course can mean different things in different settings. It may involve a prepared injectable, a substance prepared from the person receiving treatment, or a combination of assessment, procedures and follow-up. The label alone does not establish what is being proposed, whether the plan is suitable, or who will act if there is a problem.

The useful question before any first session is not whether a course sounds promising. It is whether the proposal can be recorded clearly enough to be checked later. A reader should be able to put one dated document beside the actual treatment record and see whether the material, timetable, review criteria and responsible people match what was agreed. [PLAN-01]

This is particularly important where a course is described as regenerative. That word can describe an intended biological rationale, but it does not identify a substance, a legal classification, a technique or a proven outcome. Ask for the specific material and procedure in ordinary language, then ask for the formal product or preparation identity recorded in the clinical notes. [PLAN-02]

A plan should separate facts from expectations. Facts include the intended material, route of administration, proposed dates, batch or preparation record, clinician and review date. Expectations are proposed aims and the uncertainty around them. A plan that does not distinguish those categories makes it harder to tell later whether an apparent change is a result, a temporary variation, photography differences, altered hair care, or a change in the underlying condition. [PLAN-03]

Keep the version agreed before treatment. If the proposal changes, ask for the change, its reason and the new review point to be dated. A changing plan is not automatically inappropriate, but an undocumented change removes the baseline needed for meaningful consent and follow-up. [PLAN-04]

Identify the material, not just the treatment category

Ask the clinician to write down what will enter the scalp or surrounding tissue. A category such as regenerative injectable, hair injectable or skin booster is not a sufficient identity. The record should state whether the material is a prepared product, an autologous preparation made from the recipient's own sample, or another type of preparation. It should also state the intended route and whether anything else is to be injected at the same appointment. [IDENTITY-01]

For a prepared product, the record should include its full product name as shown on the packaging, the legal manufacturer named on that packaging, the lot or batch identifier where applicable, expiry information where applicable, and the quantity intended for use. A reader need not decide the product's regulatory status alone. They do need enough information to identify what was used if a reaction, complaint or later clinical question arises. [IDENTITY-02]

For a preparation derived from the recipient's own blood or tissue, ask what sample is taken, what processing steps are planned, where preparation happens, how the preparation is identified during the appointment, and whether any additional substances are introduced. The record should make clear which part is derived from the recipient and which part, if any, is externally supplied. [IDENTITY-03]

Where the proposed material is polynucleotide-based, ask for the exact product identity and the declared origin of the starting material. Source information can matter for allergy discussion, traceability and personal acceptability. It does not by itself demonstrate that the material will improve hair growth. [IDENTITY-04]

Do not accept a photograph of a box as the whole record. Packaging can assist identification, but the clinical record should connect the identified material to the named person, date, planned site and practitioner. If the material cannot be identified in writing before the procedure, there is no reliable basis for comparing the proposal with what was administered. [IDENTITY-05]

Get the proposed schedule and its basis in writing

A course is a sequence of decisions, not merely a number of appointments. Request a dated schedule showing the intended first procedure, intervals between later sessions, any planned maintenance or reassessment, and the point at which the plan will be reviewed. If dates are provisional, the document should say which elements are provisional and what will determine the next date. [SCHEDULE-01]

Then ask where the schedule comes from. The answer may be product instructions, a published protocol, the clinician's own practice, a tailored decision based on the assessment, or a combination. These are not interchangeable. Recording the basis does not establish that the schedule is effective, but it prevents a generic timetable from being presented later as if it were individually necessary. [SCHEDULE-02]

Ask what baseline is being used before the first procedure. A useful baseline may include the history of shedding or thinning, examination findings, standardised photographs where appropriate, relevant concurrent treatment, and factors that could affect interpretation. The record should state who takes the photographs, how they are stored, and whether the same method is intended at review. [SCHEDULE-03]

The schedule should also say what is not included. For example, it should distinguish injections from consultation, photography, blood tests, prescribing, topical treatment, oral treatment, referral and follow-up. This avoids a later disagreement about whether a review was part of the original plan or an additional arrangement. [SCHEDULE-04]

A fixed schedule should not prevent clinical reassessment. Ask what circumstances would justify delaying, changing or cancelling a session, including a reaction, illness, a changed diagnosis, pregnancy-related considerations, medication changes or uncertainty about the material. The answer should be specific to the person and procedure rather than a generic reassurance. [SCHEDULE-05]

Set the review point and stopping rule before treatment starts

A review point is not simply the next appointment. It is the agreed moment when the available record will be examined and a decision made about whether to continue, alter, pause, investigate another cause or stop. Put the intended review date or time window in writing before the first procedure. [REVIEW-01]

Ask what observations will be compared at review. Hair density, shedding, calibre, scalp symptoms and photographs may all be discussed, but they should not be treated as interchangeable. The plan should specify which observations matter in this case, how they will be gathered, and what would make comparison unreliable. [REVIEW-02]

The stopping rule should be equally clear. It can include lack of an agreed change by the review point, a suspected adverse reaction, inability to verify the material used, a new clinical concern, or a decision that the original working explanation for hair change needs reconsideration. It should not be left as an undefined instruction to continue until the recipient feels satisfied. [REVIEW-03]

Ask whether the clinician will record an outcome even if treatment stops. A short closing note should state what was observed, whether there was a complication, whether the planned objective was met, and what follow-up or referral was advised. This matters because stopping is information, not a failure to be concealed. [REVIEW-04]

No written stopping rule can guarantee a result or eliminate clinical judgement. Its purpose is narrower: it prevents the review standard being silently moved after several procedures have already taken place. If the proposed course has no identifiable review point, consider postponing the decision until one is documented. [REVIEW-05]

Know who is accountable and what redress exists

Before treatment, identify the person with clinical responsibility for the assessment and plan, the person who will carry out the injection, and the person who will make decisions if a concern develops between appointments. These may be the same person, but they should not be assumed to be. Record names, professional roles and the route for contacting the service about an urgent concern or a non-urgent complaint. [ACCOUNT-01]

Ask who has assessed whether the proposed procedure is appropriate, who obtained consent, and who can change the plan. If prescribing is involved, ask who is responsible for the prescribing decision and how that person has assessed the recipient. A remote exchange or a form does not, by itself, explain accountability for a clinical decision. [ACCOUNT-02]

Ask for the service's written complaints process and the relevant route if the concern is not resolved. Also ask what indemnity or insurance arrangements cover the practitioner and procedure, and whether any limits or exclusions are relevant to the proposed work. The point is not to obtain a promise of an outcome. It is to know, before treatment, where a complaint or claim would be directed and what records can be requested. [ACCOUNT-03]

Professional titles can be important, but they are not a substitute for a documented responsibility chain. The key practical question is: if there is a reaction, an infection concern, a disputed record or no agreed review, who is required to respond and who can access the procedure record? [ACCOUNT-04]

Rules and oversight arrangements can differ across the UK and can change. This checklist does not determine whether a particular person may lawfully perform a particular procedure. It helps a reader ask for the accountable people and records needed to examine that question separately. [ACCOUNT-05]

Use this decision rule if the plan is incomplete

The following rule is designed to be saved or printed before a first session. It does not decide whether an injectable is clinically appropriate. It decides whether the proposal is documented enough to proceed to an informed discussion. A missing item can sometimes be supplied promptly. Repeated vagueness is itself relevant information about record-keeping and accountability. [RULE-01]

If every row can be answered, keep a copy of the plan and compare it with the record after each session. If a row cannot be answered, the appropriate next step is usually clarification rather than pressure to decide on the day. [RULE-02]

Plan now for the possibility that nothing changes

A no-change plan should be agreed before treatment because interpretation becomes more difficult once time, expectation and repeated procedures are involved. Ask what will happen if the agreed review finds no meaningful change, if photographs cannot be compared reliably, or if the original pattern of hair change appears inconsistent with the initial explanation. [NOCHANGE-01]

The written plan should state whether the next step would be to stop, pause, repeat assessment, seek a medical opinion about an alternative cause, or consider a referral. It should also state whether any further procedure would require a new consent discussion rather than being treated as an automatic extension of the original course. [NOCHANGE-02]

Ask how the practitioner will distinguish lack of observed change from an unmeasured change. If the answer relies on photographs, clarify whether lighting, hair length, parting, styling and camera position will be controlled as far as practical. If the answer relies on the recipient's account, clarify how that account will be recorded alongside the baseline concern. [NOCHANGE-03]

Do not let a no-change outcome be converted automatically into a more intensive version of the same plan. A new material, altered interval, added injectable or changed technique is a material change. It should have its own stated rationale, risk discussion, accountability and review rule. [NOCHANGE-04]

The same applies if symptoms worsen. New pain, inflammation, sudden shedding or other concerning change should trigger assessment rather than an assumption that the course simply needs more time. The person responsible for the plan should explain what contact route to use and what records to bring if review is needed outside the scheduled appointment. [NOCHANGE-05]

Limits of this checklist

This checklist concerns the written plan before a regenerative hair injectable course. It does not diagnose hair loss, determine whether an injectable is suitable, compare treatment options, or predict an outcome. It also does not replace individual clinical assessment, emergency care or advice about a new or worsening symptom. [LIMIT-01]

It applies to readers considering a course involving injections for a hair or scalp concern. It may be less relevant where there is no injectable procedure, where urgent medical assessment is needed, or where a clinician has advised against treatment. It is not a template for self-injection or for obtaining materials outside appropriate clinical arrangements. [LIMIT-02]

The checklist does not settle legal status, professional scope, premises requirements, insurance validity or redress rights for any specific provider. Those issues depend on the material, setting, professional role, nation of the UK and facts of the individual case. Ask for the documents relevant to the proposed arrangement rather than relying on a general description. [LIMIT-03]

Finally, a complete plan is evidence of clearer preparation, not evidence that a course will work or be free from risk. Its value is that it makes the decision, the records and the stopping point inspectable before a procedure begins. [LIMIT-04]